Anticoagulant and Fibrinolytic Drugs – Possible Agents in Treatment of Lung Cancer?

E-ISSN： 1875-5992|12|6|580-588

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.12, Iss.6, 2012-07, pp. : 580-588

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 79-101

Bentham Science Publishers

Access to resources Recommend Favorite

The role of new agents in the treatment of non-small cell lung cancer

By Broker L.E. Giaccone G.

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2347-2361

Elsevier

Access to resources Recommend Favorite

Antiangiogenic Agents for the Treatment of Nonsmall Cell Lung Cancer: Characterizing the Molecular Basis for Serious Adverse Events

By Wu Shenhong Keresztes Roger S.

Cancer Investigation, Vol. 29, Iss. 7, 2011-07 ,pp. : 460-471

Informa Healthcare

Access to resources Recommend Favorite

Is lung cancer screening possible with digital chest tomosynthesis?

By Terzi Alberto Bertolaccini Luca

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 337-339

Future Medicine

Access to resources Recommend Favorite

Trends in Biotechnological Drugs for Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 1, 2016-02 ,pp. : 112-120

Bentham Science Publishers

Access to resources Recommend Favorite